Superficial Vein Thrombosis

Chapter

Abstract

Superficial vein thrombosis (SVT), also known as superficial thrombophlebitis, is historically thought of as a benign condition that can always be treated symptomatically with nonsteroidal antiinflammatory drugs (NSAIDs) and elastic compression. However, many studies have reported an association of SVT with venous thromboembolism (VTE), with rates of concomitant deep vein thrombosis (DVT) as high as 53% and pulmonary embolism (PE) as high as 33% with lung scanning. In addition, SVT recurrence and extension is often reported. Although well-designed, randomized, controlled trials are few in this patient population, data suggest that anticoagulation in general and low-molecular-weight heparins specifically are the most effective treatment for SVT for resolving symptoms, preventing SVT recurrence or extension, and preventing VTE. When the significant morbidity and mortality associated with VTE is considered, it is reasonable that anticoagulation be used in all patients with SVT.

Keywords

Placebo Obesity Aspirin Heparin Immobilization 

Notes

Acknowledgements

The authors would like to acknowledge the editorial assistance of Holly Capasso-Harris, Ph.D. in the preparation of this chapter.

References

  1. 1.
    Coon WW, Willis 3rd PW, Keller JB. Venous ­thromboembolism and other venous disease in the Tecumseh community health study. Circulation. 1973;48:839–46.PubMedCrossRefGoogle Scholar
  2. 2.
    Blumenberg RM, Barton E, Gelfand ML, Skudder P, Brennan J. Occult deep venous thrombosis complicating superficial thrombophlebitis. J Vasc Surg. 1998;27:338–43.PubMedCrossRefGoogle Scholar
  3. 3.
    Decousus H, Epinat M, Guillot K, Quenet S, Boissier C, Tardy B. Superficial vein thrombosis: risk factors, diagnosis, and treatment. Curr Opin Pulm Med. 2003;9:393–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Superficial Thrombophlebitis Treated by Enoxaparin Study Group. A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis. Arch Intern Med. 2003;163:1657–63.CrossRefGoogle Scholar
  5. 5.
    Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton 3rd LJ. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med. 1999;159:445–53.PubMedCrossRefGoogle Scholar
  6. 6.
    Marchiori A, Mosena L, Prandoni P. Superficial vein thrombosis: risk factors, diagnosis, and treatment. Semin Thromb Hemost. 2006;32:737–43.PubMedCrossRefGoogle Scholar
  7. 7.
    Leon L, Giannoukas AD, Dodd D, Chan P, Labropoulos N. Clinical significance of superficial vein thrombosis. Eur J Vasc Endovasc Surg. 2005;29:10–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Lutter KS, Kerr TM, Roedersheimer LR, Lohr JM, Sampson MG, Cranley JJ. Superficial thrombophlebitis diagnosed by duplex scanning. Surgery. 1991;110:42–6.PubMedGoogle Scholar
  9. 9.
    Husni EA, Williams WA. Superficial thrombophlebitis of lower limbs. Surgery. 1982;91:70–4.PubMedGoogle Scholar
  10. 10.
    Subramaniam P, Van Doornum S. Superficial thrombophlebitis: underlying hypercoagulable states. Aust N Z J Surg. 1999;69:461–3.PubMedCrossRefGoogle Scholar
  11. 11.
    Unno N, Mitsuoka H, Uchiyama T, Yamamoto N, Saito T, Ishimaru K, et al. Superficial thrombophlebitis of the lower limbs in patients with varicose veins. Surg Today. 2002;32:397–401.PubMedCrossRefGoogle Scholar
  12. 12.
    De Maeseneer MG. Superficial thrombophlebitis of the lower limb: practical recommendations for diagnosis and treatment. Acta Chir Belg. 2005;105:145–7.PubMedGoogle Scholar
  13. 13.
    Martinelli I, Cattaneo M, Taioli E, De Stefano V, Chiusolo P, Mannucci PM. Genetic risk factors for superficial vein thrombosis. Thromb Haemost. 1999;82:1215–7.PubMedGoogle Scholar
  14. 14.
    Mozes G, Kalra M, Carmo M, Swenson L, Gloviczki P. Extension of saphenous thrombus into the femoral vein: a potential complication of new endovenous ablation techniques. J Vasc Surg. 2005;41:130–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Hanson JN, Ascher E, DePippo P, Lorensen E, Scheinman M, Yorkovich W, et al. Saphenous vein thrombophlebitis (SVT): a deceptively benign disease. J Vasc Surg. 1998;27:677–80.PubMedCrossRefGoogle Scholar
  16. 16.
    Caprini JA, Goldshteyn S, Glase CJ, Hathaway K. Thrombophilia testing in patients with venous thrombosis. Eur J Vasc Endovasc Surg. 2005;30:550–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Leon Jr LR, Labropoulos N. Superficial vein thrombosis and hypercoagulable states: the evidence. Perspect Vasc Surg Endovasc Ther. 2005;17:43–6.PubMedCrossRefGoogle Scholar
  18. 18.
    de Godoy JM, Braile DM. Protein S deficiency in repetitive superficial thrombophlebitis. Clin Appl Thromb Hemost. 2003;9:61–2.PubMedCrossRefGoogle Scholar
  19. 19.
    de Moerloose P, Wutschert R, Heinzmann M, Perneger T, Reber G, Bounameaux H. Superficial vein thrombosis of lower limbs: influence of factor V Leiden, factor II G20210A and overweight. Thromb Haemost. 1998;80:239–41.PubMedGoogle Scholar
  20. 20.
    Vaya A, Llopis I, Trenor R, Mira Y, Estelles A, Aznar J. Spontaneous superficial vein thrombosis in a young patient double heterozygous for factor V Leiden and the prothrombin G20210A mutation: a case report. Haematologica. 2000;85:E11.PubMedGoogle Scholar
  21. 21.
    Lofgren EP, Lofgren KA. The surgical treatment of superficial thrombophlebitis. Surgery. 1981;90:49–54.PubMedGoogle Scholar
  22. 22.
    Heit JA, Silverstein MD, Mohr DN, Petterson TM, Lohse CM, O’Fallon WM, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost. 2001;86:452–63.PubMedGoogle Scholar
  23. 23.
    Verlato F, Zucchetta P, Prandoni P, Camporese G, Marzola MC, Salmistraro G, et al. An unexpectedly high rate of pulmonary embolism in patients with superficial thrombophlebitis of the thigh. J Vasc Surg. 1999;30:1113–5.PubMedCrossRefGoogle Scholar
  24. 24.
    Porter JM, Moneta GL. Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease. J Vasc Surg. 1995;21:635–45.PubMedCrossRefGoogle Scholar
  25. 25.
    Quenet S, Laporte S, Decousus H, Leizorovicz A, Epinat M, Mismetti P. Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosis. J Vasc Surg. 2003;38:944–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Hafner CD, Cranley JJ, Krause RJ, Strasser ES. A method of managing superficial thrombophlebitis. Surgery. 1964;55:201–6.PubMedGoogle Scholar
  27. 27.
    Partsch H. Compression therapy of the legs. A review. J Dermatol Surg Oncol. 1991;17:799–805.PubMedGoogle Scholar
  28. 28.
    Partsch H, Blattler W. Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin. J Vasc Surg. 2000;32:861–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Belcaro G, Nicolaides AN, Errichi BM, Cesarone MR, De Sanctis MT, Incandela L, et al. Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study. Angiology. 1999;50:523–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Titon JP, Auger D, Grange P, Hecquet JP, Remond A, Ulliac P, et al. Therapeutic management of superficial venous thrombosis with calcium nadroparin. Dosage testing and comparison with a non-steroidal anti-inflammatory agent. Ann Cardiol Angeiol (Paris). 1994;43:160–6.Google Scholar
  31. 31.
    Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:338S–400.PubMedCrossRefGoogle Scholar
  32. 32.
    Marchiori A, Verlato F, Sabbion P, Camporese G, Rosso F, Mosena L, et al. High versus low doses of unfractionated heparin for the treatment of superficial thrombophlebitis of the leg. A prospective, controlled, randomized study. Haematologica. 2002;87:523–7.PubMedGoogle Scholar
  33. 33.
    Ascher E, Lorensen E, Pollina RM, Gennaro M. Preliminary results of a nonoperative approach to saphenofemoral junction thrombophlebitis. J Vasc Surg. 1995;22:616–21.PubMedCrossRefGoogle Scholar
  34. 34.
    Ascher E, Hanson JN, Salles-Cunha S, Hingorani A. Lesser saphenous vein thrombophlebitis: its natural history and implications for management. Vasc Endovascular Surg. 2003;37:421–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Lozano FS, Almazan A. Low-molecular-weight heparin versus saphenofemoral disconnection for the treatment of above-knee greater saphenous thrombophlebitis: a prospective study. Vasc Endovascular Surg. 2003;37:415–20.PubMedCrossRefGoogle Scholar
  36. 36.
    Di Nisio M, Middeldorp S, Wichers IM. Treatment for superficial thrombophlebitis of the leg. Cochrane Database Syst Rev. 2007;(1):CD004982.Google Scholar
  37. 37.
    Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med. 2002;162:1833–40.PubMedCrossRefGoogle Scholar
  38. 38.
    Decousus H, Leizorovicz A, Prandoni P. Haemostasis; “Fondaparinux 2.5 mg for the treatment of symptomatic, isolated superficial vein thrombosis (SVT): Preliminary data from the randomized placebo-controlled CALISTO Trial (on behalf of the CALISTO Investigators)”. ASH 2009; Abstract 171.Google Scholar
  39. 39.
    Beatty J, Fitridge R, Benveniste G, Greenstein D. Acute superficial venous thrombophlebitis: does emergency surgery have a role? Int Angiol. 2002;21:93–5.PubMedGoogle Scholar
  40. 40.
    Lohr JM, McDevitt DT, Lutter KS, Roedersheimer LR, Sampson MG. Operative management of greater saphenous thrombophlebitis involving the saphenofemoral junction. Am J Surg. 1992;164:269–75.PubMedCrossRefGoogle Scholar
  41. 41.
    Plate G, Eklof B, Jensen R, Ohlin P. Deep venous thrombosis, pulmonary embolism and acute surgery in thrombophlebitis of the long saphenous vein. Acta Chir Scand. 1985;151:241–4.PubMedGoogle Scholar
  42. 42.
    Gjores JE. Surgical therapy of ascending thrombophlebitis in the saphenous system. Angiology. 1962;13:241–3.PubMedCrossRefGoogle Scholar
  43. 43.
    Sullivan V, Denk PM, Sonnad SS, Eagleton MJ, Wakefield TW. Ligation versus anticoagulation: treatment of above-knee superficial thrombophlebitis not involving the deep venous system. J Am Coll Surg. 2001;193:556–62.PubMedCrossRefGoogle Scholar
  44. 44.
    Yamaki T, Nozaki M, Sasaki K. Acute massive pulmonary embolism following high ligation combined with compression sclerotherapy for varicose veins report of a case. Dermatol Surg. 1999;25:321–5.PubMedCrossRefGoogle Scholar
  45. 45.
    Ikeda M, Kambayashi J, Iwamoto S, Shinoki N, Nakamura T, Okahara K, et al. Hemostasis activation during sclerotherapy of lower extremity varices. Thromb Res. 1996;82:87–95.PubMedCrossRefGoogle Scholar
  46. 46.
    Neglen P, Einarsson E, Eklof B. High tie sclerotherapy for saphenous vein insufficiency. Phlebology. 1986;1:105–11.Google Scholar
  47. 47.
    Rutherford RB, Sawyer JD, Jones DN. The fate of residual saphenous vein after partial removal or ligation. J Vasc Surg. 1990;12:422–6; discussion 426–8.PubMedGoogle Scholar
  48. 48.
    Bishop CC, Fronek HS, Fronek A, Dilley RB, Bernstein EF. Real-time color duplex scanning after sclerotherapy of the greater saphenous vein. J Vasc Surg. 1991;14:505–8; discussion 508–10.PubMedCrossRefGoogle Scholar
  49. 49.
    Goren G. Real-time color duplex scanning after sclerotherapy of the greater saphenous vein. J Vasc Surg. 1992;16:497–8.PubMedCrossRefGoogle Scholar
  50. 50.
    Prandoni P, Tormene D, Pesavento R. High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs: a double-blind, randomized trial. J Thromb Haemost. 2005;3:1152–7.PubMedCrossRefGoogle Scholar
  51. 51.
    Gervais M. Les Thromboses veineuses superficielles. Lyon Chir. 1956;52:89–96.PubMedGoogle Scholar
  52. 52.
    Zollinger R, Williams RD, Briggs DO. Problems in the diagnosis and treatment of thrombophlebitis. Arch Surg. 1962;85:34–40.CrossRefGoogle Scholar
  53. 53.
    Bergqvist D, Jaroszewski H. Deep vein thrombosis in patients with superficial thrombophlebitis of the leg. Br Med J (Clin Res Ed). 1986;292:658–9.CrossRefGoogle Scholar
  54. 54.
    Skillman JJ, Kent KC, Porter DH, Kim D. Simultaneous occurrence of superficial and deep thrombophlebitis in the lower extremity. J Vasc Surg. 1990;11:818–23.PubMedGoogle Scholar
  55. 55.
    Prountjos P, Bastounis E, Hadjinikolaou L, Felekuras E, Balas P. Superficial venous thrombosis of the lower extremities co-existing with deep venous thrombosis. A phlebographic study on 57 cases. Int Angiol. 1991;10:63–5.PubMedGoogle Scholar
  56. 56.
    Pulliam CW, Barr SL, Ewing AB. Venous duplex scanning in the diagnosis and treatment of progressive superficial thrombophlebitis. Ann Vasc Surg. 1991;5:190–5.PubMedCrossRefGoogle Scholar
  57. 57.
    Jorgensen JO, Hanel KC, Morgan AM, Hunt JM. The incidence of deep venous thrombosis in patients with superficial thrombophlebitis of the lower limbs. J Vasc Surg. 1993;18:70–3.PubMedCrossRefGoogle Scholar
  58. 58.
    Chengelis DL, Bendick PJ, Glover JL, Brown OW, Ranval TJ. Progression of superficial venous thrombosis to deep vein thrombosis. J Vasc Surg. 1996;24:745–9.PubMedCrossRefGoogle Scholar
  59. 59.
    Somjen GM, Donlan J, Hurse J, Bartholomew J, Weir E, Johnston AH, et al. Duplex ultrasound examination of the acutely painful and swollen leg. Dermatol Surg. 1996;22:383–7.PubMedCrossRefGoogle Scholar
  60. 60.
    Bounameaux H, Reber-Wasem MA. Superficial thrombophlebitis and deep vein thrombosis. A controversial association. Arch Intern Med. 1997;157:1822–4.PubMedCrossRefGoogle Scholar
  61. 61.
    Murgia AP, Cisno C, Pansini GC, Manfredini R, Liboni A, Zamboni P. Surgical management of ascending saphenous thrombophlebitis. Int Angiol. 1999;18:343–7.PubMedGoogle Scholar
  62. 62.
    Gorty S, Patton-Adkins J, DaLanno M, Starr J, Dean S, Satiani B. Superficial venous thrombosis of the lower extremities: analysis of risk factors, and recurrence and role of anticoagulation. Vasc Med. 2004;9:1–6.PubMedCrossRefGoogle Scholar
  63. 63.
    De Sanctis MT, Cesarone MR, Incandela L, Belcaro G, Griffin M. Treatment of superficial vein thrombophlebitis of the arm with Essaven gel – a placebo-controlled, randomized study. Angiology. 2001;52 suppl 3:S63–7.PubMedCrossRefGoogle Scholar
  64. 64.
    Agus GB, de Angelis R, Mondani P, Moia R. Double-blind comparison of nimesulide and diclofenac in the treatment of superficial thrombophlebitis with telethermographic assessment. Drugs. 1993;46 suppl 1:200–3.PubMedCrossRefGoogle Scholar
  65. 65.
    Williams RD, Zollinger RW. Surgical treatment of superficial thrombophlebitis. Surg Gynecol Obstet. 1964;118:745–7.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  1. 1.Division of Vascular Surgery, Department of SurgeryNorthShore University HealthSystemEvanstonUSA
  2. 2.The University of Chicago Pritzker School of MedicineChicagoUSA
  3. 3.Department of SurgeryNorthwestern University Feinberg School of MedicineChicagoUSA

Personalised recommendations